| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | -77.1% |
| Cost of Revenue | $26.3M | -64.6% |
| Gross Profit | $340K | -99.2% |
| R&D Expense | $3.9M | -66.5% |
| SG&A Expense | $18.1M | +46.8% |
| Operating Income | -$28.0M | -453.1% |
| Pre-tax Income | -$25.8M | -384.9% |
| Income Tax | $90K | -45.1% |
| Net Income | $74.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.6M | +481.9% |
| Accounts Receivable | $4.2M | -80.8% |
| Inventory | $7.5M | -74.0% |
| Current Assets | $152.8M | +92.3% |
| Total Assets | $163.2M | +48.8% |
| Current Liabilities | $8.0M | -74.1% |
| Total Liabilities | $9.2M | -74.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | -1433.9% |
| Investing Cash Flow | $141.5M | +3507.8% |
| Financing Cash Flow | -$13.6M | -235.4% |
| +1463.1% |
| EPS (Basic) | $3.14 | +1182.8% |
| EPS (Diluted) | $3.14 | +1182.8% |
| Stockholders' Equity |
| $154.1M |
| +107.4% |